- Home
- BIAF vs FLGC Comparison
BIAF vs FLGC Comparison
Compare BIAF & FLGC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BIAF
- FLGC
- Stock Information
- Founded
- BIAF 2014
- FLGC 2019
- Country
- BIAF United States
- FLGC United States
- Employees
- BIAF N/A
- FLGC N/A
- Industry
- BIAF Biotechnology: In Vitro & In Vivo Diagnostic Substances
- FLGC Biotechnology: Pharmaceutical Preparations
- Sector
- BIAF Health Care
- FLGC Health Care
- Exchange
- BIAF Nasdaq
- FLGC Nasdaq
- Market Cap
- BIAF 14.5M
- FLGC 15.5M
- IPO Year
- BIAF 2022
- FLGC 2021
- Fundamental
- Price
- BIAF $0.99
- FLGC $1.05
- Analyst Decision
- BIAF Strong Buy
- FLGC Strong Buy
- Analyst Count
- BIAF 1
- FLGC 4
- Target Price
- BIAF $6.00
- FLGC $5.67
- AVG Volume (30 Days)
- BIAF 148.8K
- FLGC 956.1K
- Earning Date
- BIAF 11-14-2024
- FLGC 11-13-2024
- Dividend Yield
- BIAF N/A
- FLGC N/A
- EPS Growth
- BIAF N/A
- FLGC N/A
- EPS
- BIAF N/A
- FLGC N/A
- Revenue
- BIAF $9,367,785.00
- FLGC $64,154,000.00
- Revenue This Year
- BIAF $285.51
- FLGC N/A
- Revenue Next Year
- BIAF $20.05
- FLGC $8.94
- P/E Ratio
- BIAF N/A
- FLGC N/A
- Revenue Growth
- BIAF 2813.87
- FLGC N/A
- 52 Week Low
- BIAF $0.83
- FLGC $0.75
- 52 Week High
- BIAF $3.62
- FLGC $2.93
- Technical
- Relative Strength Index (RSI)
- BIAF 41.69
- FLGC 36.74
- Support Level
- BIAF $0.83
- FLGC $1.60
- Resistance Level
- BIAF $1.04
- FLGC $1.22
- Average True Range (ATR)
- BIAF 0.13
- FLGC 0.20
- MACD
- BIAF 0.02
- FLGC -0.08
- Stochastic Oscillator
- BIAF 35.25
- FLGC 7.89
About BIAF bioAffinity Technologies Inc.
bioAffinity Technologies Inc addresses the need for noninvasive diagnosis of early-stage cancer and diseases of the lung and targeted cancer treatment. It develops proprietary noninvasive diagnostic tests and cancer therapeutics using technology that preferentially targets cancer cells and cell populations indicative of a diseased state. The company's product, CyPath Lung, is a noninvasive test for the detection of early-stage lung cancer.
About FLGC Flora Growth Corp.
Flora Growth Corp is a multi-national cannabis company that manufactures and distributes consumer packaged goods, cultivates and distributes medicinal cannabis, and distributes pharmaceutical products. Its reportable segments are; the commercial and wholesale segment (FGH and Cosechemos subsidiaries), the house of brands segment (JustCBD, Vessel, and Kasa Wholefoods Company subsidiaries), and the pharmaceuticals segment (Grupo Farmaceutico Cronomed and Breeze Laboratory subsidiaries). Geographically, the company generates revenue from United States, Germany, and the United Kingdom. It derives a majority of its revenue from the United States.